MAHBUB, A.A., LE MAITRE, C.L., HAYWOOD-SMALL, S.L., CROSS, N.A. and JORDAN-MAHY, N. (2015). Glutathione is key to the synergistic enhancement of doxorubicin and etoposide by polyphenols in leukaemia cell lines. Cell Death and Disease, 6, e2028.
|
PDF
Mahbub et al - Glutathione is key to the synergistic enhancements of doxorubin.pdf - Published Version Creative Commons Attribution. Download (708kB) | Preview |
|
PDF (Acceptance e-mail)
Jordan-Mahy - 11343.pdf Restricted to Repository staff only Download (177kB) |
Abstract
Recently published in Nature: Cell Death and Discovery, Mahbub et al.1 have demonstrated that polyphenols can synergistically enhance the action of the topoisomerase II inhibitors: doxorubicin and etoposide in leukaemia cells. A reduction of glutathione (GSH) was strongly associated with sensitising cells to the pro-apoptotic effects of polyphenols when used in combination with doxorubicin or etoposide. Importantly, when polyphenols and topoisomerase II inhibitors were combined, it was possible to induce a synergistic decrease in cell proliferation (measured as ATP levels), cell-cycle arrest and induction of apoptosis in leukaemia cell lines.
Item Type: | Article |
---|---|
Research Institute, Centre or Group - Does NOT include content added after October 2018: | Biomedical Research Centre |
Identification Number: | https://doi.org/10.1038/cddis.2015.379 |
Page Range: | e2028 |
Depositing User: | Users 3084 not found. |
Date Deposited: | 13 Jan 2016 13:51 |
Last Modified: | 18 Mar 2021 11:41 |
URI: | https://shura.shu.ac.uk/id/eprint/11343 |
Actions (login required)
View Item |
Downloads
Downloads per month over past year